TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Vectus Biosystems Limited ( (AU:VBS) ) has issued an update.
Vectus Biosystems Limited has announced the quotation of 75,000 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move follows the exercise of options or conversion of other convertible securities, potentially enhancing the company’s capital structure and market presence.
The most recent analyst rating on (AU:VBS) stock is a Hold with a A$0.17 price target. To see the full list of analyst forecasts on Vectus Biosystems Limited stock, see the AU:VBS Stock Forecast page.
More about Vectus Biosystems Limited
Vectus Biosystems Limited operates in the biotechnology industry, focusing on the development of therapeutic products. The company is primarily engaged in creating treatments for fibrosis and high blood pressure, targeting significant health markets.
Average Trading Volume: 85,098
Technical Sentiment Signal: Hold
Current Market Cap: A$9.33M
Find detailed analytics on VBS stock on TipRanks’ Stock Analysis page.